Mackenzie Financial Corp Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mackenzie Financial Corp boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 19.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 339,906 shares of the medical equipment provider's stock after acquiring an additional 54,234 shares during the quarter. Mackenzie Financial Corp owned about 0.10% of Intuitive Surgical worth $177,417,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 3,031 shares of the business's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $577.30, for a total value of $1,749,796.30. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at $203,786.90. The trade was a 89.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Fredrik Widman sold 810 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now owns 473 shares of the company's stock, valued at $271,397.94. This trade represents a 63.13% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,299 shares of company stock valued at $15,470,640 in the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 0.6%

ISRG traded up $3.26 during midday trading on Thursday, hitting $555.67. 539,735 shares of the company were exchanged, compared to its average volume of 1,641,126. The company's 50 day simple moving average is $514.87 and its 200 day simple moving average is $538.30. The firm has a market capitalization of $199.16 billion, a price-to-earnings ratio of 86.80, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1-year low of $396.15 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period last year, the firm earned $1.50 EPS. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

A number of analysts recently issued reports on ISRG shares. Barclays lowered their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Royal Bank of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Piper Sandler lowered their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Finally, Robert W. Baird decreased their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $596.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.